Market open
Johnson & Johnson/$JNJ
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Ticker
$JNJ
Sector
Trading on
NYSE
Industry
Pharmaceuticals
Headquarters
Employees
138,100
Website
JNJ Metrics
BasicAdvanced
$395B
28.27
$5.79
0.46
$4.96
3.03%
Price and volume
Market cap
$395B
Beta
0.46
52-week high
$169.99
52-week low
$140.68
Average daily volume
9.1M
Dividend rate
$4.96
Financial strength
Current ratio
1.111
Quick ratio
0.782
Long term debt to equity
44.553
Total debt to equity
52.922
Dividend payout ratio (TTM)
84.05%
Interest coverage (TTM)
29.94%
Management effectiveness
Return on assets (TTM)
8.13%
Return on equity (TTM)
20.25%
Valuation
Price to earnings (TTM)
28.275
Price to revenue (TTM)
4.437
Price to book
5.51
Price to tangible book (TTM)
-38.15
Price to free cash flow (TTM)
21.823
Dividend yield (TTM)
3.03%
Forward dividend yield
3.03%
Growth
Revenue change (TTM)
4.30%
Earnings per share change (TTM)
-57.81%
3-year revenue growth (CAGR)
4.10%
3-year earnings per share growth (CAGR)
-9.50%
3-year dividend per share growth (CAGR)
5.43%
What the Analysts think about JNJ
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Johnson & Johnson stock.
JNJ Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
JNJ Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
JNJ News
AllArticlesVideos
Why Johnson & Johnson (JNJ), United Health (UNH) And Procter & Gamble (PG) Are Holding the S&P 500 From Dropping More
24/7 Wall Street·1 hour ago
Procter & Gamble, Johnson & Johnson Among 10 Companies To Announce Dividend Increases In First Half Of April
Seeking Alpha·22 hours ago
These 10 Stocks Have Increased Dividends For Over 60 Consecutive Years. Should You Buy Them Now?
24/7 Wall Street·1 day ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Johnson & Johnson stock?
Johnson & Johnson (JNJ) has a market cap of $395B as of March 31, 2025.
What is the P/E ratio for Johnson & Johnson stock?
The price to earnings (P/E) ratio for Johnson & Johnson (JNJ) stock is 28.27 as of March 31, 2025.
Does Johnson & Johnson stock pay dividends?
Yes, the Johnson & Johnson (JNJ) stock pays dividends to shareholders. As of March 31, 2025, the dividend rate is $4.96 and the yield is 3.03%. Johnson & Johnson has a payout ratio of 84.05% on a trailing twelve-month basis.
When is the next Johnson & Johnson dividend payment date?
The next Johnson & Johnson (JNJ) dividend payment date is unconfirmed.
What is the beta indicator for Johnson & Johnson?
Johnson & Johnson (JNJ) has a beta rating of 0.46. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.